Schafer's Biotech operation focuses on providing biological and medical
researchers with innovative, state-of-the-art tools from the fields of
physics, electrical engineering and advanced mathematics. Under National
Institute of Mental Health (NIMH) funding, we are developing both hardware
and software tools for neuroscience and neuromedicine. An example is our
development of a novel semiconductor sensing device and system called an
OSMA (Optically Switched Microelectrode Array).
OSMA provides an increase in the number of neurons that can be accessed in recording and stimulating applications of over two orders of magnitude compared to current
technology. The short term use for this device will be to help understand
the functioning of the brain. In the longer term, it may provide the basis
for the next generation of neural prostheses such as cochlear and visual
implants, pain relief, stimulation of muscles for control of arm and hand
movement, posture, bladder control, etc.
We are also developing software to discern extremely subtle relationships between lists of neural firing events. This work is critical to understand the masses of neuroscience data
that is being captured, but is also generally applicable to other large
lists of events from other fields, such as sociology or market research.
Finally, we have developed one of the fastest software simulators of
extremely large (105 neurons), randomly-distributed, biologically-realistic
neuronal networks. While this has obvious applications in neuroscience, for
the first time we may be able to reach the holy grail of performing
functions traditionally handled by artificial neural networks with networks
of biologically realistic neurons using this simulator.
By incorporating Biotech with our other laboratories, we hope to achieve
some synergism in the areas of micro- and nanotechnology, in
microfabrication and assembly of microsensors and related opto-electronic
technology, and in the general process of leveraging Schafer's capabilities,
expertise and proprietary technology into commercial products and services.